Variable | AGE | Placebo | |||
---|---|---|---|---|---|
n = 46 | SD | n = 47 | SD | P-value | |
Framingham risk score | 23 | (7) | 21 | (7) | 0.27 |
Age (years) | 63 | (6) | 64 | (6) | 0.95 |
BMI | 27.6 | (3.7) | 30.0 | (4.6) | 0.01 |
CAC | 207.3 | (237.7) | 121.0 | (178) | 0.05 |
CRP (mg/L) | 2.2 | (3.6) | 2.2 | (3.5) | 0.97 |
Triglycerides (mmol/L) | 1.4 | (0.7) | 1.6 | (1.2) | 0.21 |
Cholesterol (mmol/L) | 5.2 | (1.3) | 4.6 | (1) | 0.03 |
HDL (mmol/L) | 1.6 | (0.5) | 1.4 | (0.4) | 0.07 |
LDL (mmol/L) | 3.4 | (1.1) | 2.9 | (0.9) | 0.01 |
Il-6 (ng/L) | 4.5 | (3.7) | 4.4 | (2.3) | 0.83 |
ApoB/ApoA | 0.7 | (0.2) | 0.7 | (0.2) | 0.30 |
Homocysteine (μmol/L) | 13.4 | (3.8) | 13.2 | (3.6) | 0.76 |
Glucose (mmol/L) | 6.3 | (1.2) | 6.6 | (1.3) | 0.43 |